DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/gxjk83/2016_emerging) has announced the addition of the "2016 Emerging Opportunities in the European Drugs of Abuse Testing Market: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers--Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Re" report to their offering.
This new 300-page report provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.
2016 Emerging Opportunities in the European Drugs of Abuse Testing Market: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.
Contains 300 pages and 48 tables
- Abbott Laboratories
- Agilent Technologies
- Bayer Healthcare
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- Instrumentation Laboratory
- Kyowa Medex
- Ortho-Clinical Diagnostics
- Quest Diagnostics
- Thermo Fisher
For more information visit http://www.researchandmarkets.com/research/gxjk83/2016_emerging